Pfizer Drops Lead Obesity Asset After Liver Safety Concerns, Overall Review
Pfizer will no longer invest in the development of its oral GLP-1 drug danuglipron after the pharma detected a potential...
obesity
UK’s soaring liver cancer death rate blamed on alcohol and obesity | Cancer
One of the country’s leading health charities is calling for urgent action to reduce the “carcinogenic effects” of cheap alcohol...
